Search results
Results From The WOW.Com Content Network
Harborside, formerly Harborside Health Center, is a recreational and medical cannabis dispensary, with its flagship location in Oakland, California, and an additional location in San Jose. Founded in 2006 by Steve DeAngelo and Dave Wedding Dress, Harborside operates as a non-profit patient collective. [ 1 ]
Weed Wars is an American reality-documentary television series that documents a popular medical marijuana dispensary, Harborside Health Center, in Oakland, California. The series premiered on the Discovery Channel on December 1, 2011. [1] The series has since been cancelled. [2]
Steve DeAngelo is a co-founder and chairman emeritus of Harborside Inc., a publicly-traded cannabis company listed on the Canadian Securities Exchange. Harborside Health Center was founded in 2006 as a non-profit medical cannabis dispensary and had more than 300,000 registered medical patients.
For premium support please call: 800-290-4726 more ways to reach us
TALLAHASSEE, Fla. (AP) — Florida has more than 700,000 medical marijuana patients and Republican Gov. Ron DeSantis — who is battling a proposal to allow recreational use of marijuana — wants ...
Cannabis Station, a medical cannabis dispensary in Denver, Colorado Cannabis flower stored in jars at a dispensary in Colorado. Cannabis dispensaries in the United States or marijuana dispensaries are a type of cannabis retail outlet, local government-regulated physical location, typically inside a retail storefront or office building, in which a person can purchase cannabis and cannabis ...
California-focused cannabis company Harborside Inc. (CSE: HBOR) (OTCQX: HBORF) entered into an agreement to buy an Oakland-based cannabis manufacturer Sublimation Inc. (“Sublime”) for $43.8 ...
A medical cannabis card in California. A medical cannabis card or medical marijuana card is a state-issued identification card that enables a patient with a doctor's recommendation to obtain, possess, or cultivate cannabis for medicinal use despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy.